News and Announcements
Read the latest news from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The links below take you to articles where you can learn more about our center's latest events and accomplishments. You can also visit the article archive for older news.
Gene therapy delivers novel solution for treating serious blood disease, beta thalassemia.
Lurie Cancer Center oncology nurses Natalia Ogara, RN, and Kathleen Creighton, RN, rose to the occasion when their commute to Northwestern Memorial Hospital took an unexpected turn.
Chicago firefighter Patrick Jessee is accustomed to rescuing others. As a patient with cancer, he became an advocate for his own care, and for the power of discovery. “I’m here because of research – and some luck.”
The three-dimensional atomic structure of the epigenetic driver COMPASS was solved for the first time in a study published in the journal Cell.
Christie Sze, a graduate student in the Department of Biochemistry and Molecular Genetics, has received the National Cancer Institute (NCI) Predoctoral to Postdoctoral Fellow Transition Award (F99/K00).
A drug called mogamulizumab significantly improved progression-free survival for patients with cutaneous T-cell lymphoma, according to a study published in The Lancet Oncology.
A bill based in part on research and advocacy at Northwestern amends the Illinois insurance code to require oncofertility coverage, which requires insurance to cover fertility preservation.
Patient Navigator for Fertility Preservation, Kristin Smith, traveled to the state capital many times on behalf of the Oncofertility Consortium in support of law HB2617, which will ensure insurance coverage for fertility preservation in Illinois.
Lurie Cancer Center member, Erik Andersen, PhD, has received a Faculty Early Career Development Program award from the National Science Foundation, the foundation’s most prestigious honor for junior faculty members.
Cancer Isn’t a War or a Battle, but Maybe Cancer Research Is For patients, “cancer isn’t a battle or a test of toughness,” says Suneel Kamath, MD, in this powerful Chicago Tribune Commentary. “However, the researcher in me does feel like we aren’t winning the cancer research battle fast enough.”
Leonidas Platanias, MD, PhD, director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Jesse, Sara, Andrew, Abigail, Benjamin and Elizabeth Lurie Professor of Oncology, was elected to the Association of American Cancer Institutes (AACI) Board of Directors.
The Robert H. Lurie Comprehensive Cancer Center has been awarded a new, five-year $11.5 million grant from the National Cancer Institute to advance translational brain cancer research.
Cancer care at Northwestern Memorial was once again recognized among the nation’s best. The clinical home of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University was ranked 12th in the nation, and ranked first in Illinois and the Chicago Metro Area for seven years in a row.
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University has been renewed for a fourth five-year grant, totaling $31.5 million and representing a 36 percent increase over its previous funding.
Highest possible rating and big funding boost for Lurie Cancer Center • Ranked as “exceptional” with a near-perfect impact score of 12 • Lurie Cancer Center will receive nearly $31.5 million in funding, a dramatic 36 percent increase
John Lurain, MD, helps develop guidelines for treatment of people with gestational trophoblastic neoplasia.
The Lurie Cancer Center has received two individual supplements from the NCI to the Cancer Center Support Grant to stimulate research in Non-AIDS Defining Cancers (NADCs) in Aging Populations, and in HIV/AIDS-related malignancies.
Despite these positive trends, cancer survivorship remains a difficult journey for many. A majority of cancer survivors experience significant fatigue. Issues like depression, anxiety, post-traumatic stress disorder, and chronic pain can be problematic, even years after treatment ends. So, what can a survivor do?
When Pat Ward needed help, neurosurgeon James Chandler, MD, was there. Now she’s lighting the way for others.
A proteomics pioneer works to improve a flawed test for a common cancer
See more news in the article archive.